Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI
Review

[Disease associated with anti-myelin oligodendrocyte glycoprotein (MOGAD)].

Florencia Pérez-Vidarte Alfredo Cerisola R. Chávez Nicolás M. Espinoza Aroldo Morón Virginia Pedemonte Marcelo Román Alcy R. Torres A. Savransky
Aug 2026 · Medicina · Vol 86 Suppl 3, pp. 177-181 · 0 citations
Medicine

TL;DR

The disease associated with antibodies against myelin oligodendrocyte glycoprotein (MOGAD) is an inflammatory demyelinating disorder of the central nervous system, with acute disseminated encephalomyelitis in children, and optic neuritis and transverse myelitis more frequently observed in adults.

PubMed Semantic Scholar
View source

Similar papers

Open access Sep 2026

Pediatric myelin oligodendrocyte glycoprotein antibody associated disease following incomplete Kawasaki – a case report with varied association

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has emerged as a distinct inflammatory demyelinating disorder of the central nervous system. Although relatively rare, growing recognition of this entity has highlighted important differences from multiple sclerosis and neuromyelitis optica spectru...

Kavya Rajanna, G. Sharma · 0 citations
Review Open access Sep 2026

[Myelin oligodendrocyte glycoprotein antibody-associated disease].

MOG-antibody-associated disease (MOGAD) is a rare inflammatory demyelinating CNS condition. Diagnosis is based on core clinical symptoms supported by additional clinical/MRI data if necessary, depending on the antibody titer in the blood. The clinical presentation is age-dependent. Due to its recent recognition, manage...

M. Børresen, J. Christensen, K. Linnet et al. · 0 citations
Review Open access Sep 2026

Malignant Intracranial Pressure Elevation in MOGAD Meningoencephalitis.

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) was first proposed as a distinct demyelinating disorder about a decade ago; however, its entire range of phenotypes has yet to be established. We present a case of a 15-year-old boy with features of viral meningoencephalitis with refractory elevate...

Celeste R. S. Camargo, Amanda Spinner, Vikram Bhise · 0 citations
Review Sep 2026

Recognition and management of acute relapse of multiple sclerosis, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.

The clinical patterns of acute attacks and relapses of multiple sclerosis, NMOSD and MOGAD are discussed, including the clinical and para-clinical modalities that are critical for timely recognition and diagnosis, and available evidence regarding treatment selection and responsiveness is presented.

Yu-Jing Li, Wei Jiang, Chao Zhang et al. · 0 citations
Review Open access Aug 2026

MOGAD-Like Encephalitic Syndromes Without MOG Antibodies in Children

Children can develop the full spectrum of MOGAD-like encephalitis without MOG-IgG, including lesion distribution, frequency of associated longitudinally extensive transverse myelitis, lesion resolution, and functional outcomes.

G. Olivé-Cirera, E. Fonseca, M. Guasp et al. · 0 citations
Open access Sep 2026

Rheumatologic profile in CNS demyelinating disorders

Serum rheumatologic markers such as ANA, Anti dsDNA, ESR, CRP and RA factor are related to CNS demyelination and further studies may be needed to determine the long term significance of these markers.

Ravindra N. Singh, Pankajkumar Sharma, Swati Garg et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.